DEPEMOKIMAB
UNII D16EQP0KKH

Substance Identification & Data

This profile provides standardized clinical and technical data for Depemokimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D16EQP0KKH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2243274-14-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D16EQP0KKH

CAS Registry Number

2243274-14-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DEPEMOKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

D16EQP0KKH

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C175768

National Cancer Institute reference terminology for clinical and research data.

INN ID

11449

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-143

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Depemokimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DEPEMOKIMAB

DEPEMOKIMAB-ULAA

Common Names & Synonyms

DEPEMOKIMAB [INN]

DEPEMOKIMAB [USAN]

DEPEMOKIMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 5) (HUMAN-MUS MUSCULUS MONOCLONAL GSK3511294 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GSK3511294 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL5 (INTERLEUKIN 5, IL-5)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-449) (VH HUMANIZED (HOMO SAPIENS IGHV2-70*19 (75.8%)-(IGHD)-IGHJ4*01 (85.7%)) CDR-IMGT (8.7.13) (26-33.51-57.96-108) (1-119)-HOMO SAPIENS IGHG1*03 G1M3, NG1M1, G1V21 CH2 Y15.1, T16, E18 (CH1 R120 (216) (120-217), HINGE 1-15 (218-232), CH2 M15.1>Y (254), S16>T (256), T18>E (258) (233-342), CH3 E12 (358), M14 (360) (343-447), CHS (448-449)) (120-449)), (222-220')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-220') (V-KAPPA (HOMO SAPIENS IGKV4-1*01 (91.1%)-IGKJ2*02 (90.9%)) CDR-IMGT (12.3.9) (27-38.56-58.95-103) (1'-113')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (159), V101 (197) (114'-220')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE LACKING THE GLUTAMINE SYNTHETASE (GS) GENE, GLYCOFORM ALFA

RECOMBINANT HUMAN IGG1 KAPPA ANTI-IL-5 MONOCLONAL ANTIBODY GSK3511294